DepMap data suggest that inhibition of SIAH3 results in proliferation in PDAC cells and in RAS-driven lung cancer cells (Figure 3G), and TCGA clinical samples show a progressive decrease in SIAH3 expression in advanced PDAC stages (Figure 4A). This evidence concerns the gene SIAH3 and lung cancer.